Neurocrine Biosciences (NBIX) Asset Utilization Ratio (2011 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Asset Utilization Ratio of 0.66 for Q2 2026, down 0.77% year-over-year from 0.66 in Q2 2025, and up 1.04% on a QoQ basis from 0.65 in Q1 2026.
Neurocrine Biosciences (NBIX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.66 in Q2 2026.
- Asset Utilization Ratio for Q2 2026 came in at 0.66, down 0.77% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.66 (down 0.77% YoY), and the FY2025 annual result was 0.69, up 1.38% from the prior year.
- Asset Utilization Ratio grew to 0.66 in Q2 2026, from 0.65 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.67 in Q2 2023 and troughed at 0.45 in Q2 2022.
- A 5-year average of 0.61 and a median of 0.65 in 2024 frame the typical range for Asset Utilization Ratio.
- The widest annual swing landed in 2022, when Asset Utilization Ratio slipped 16.66%; it then soared 48.76% in 2023.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.5 in 2022, then increased by 23.48% to 0.62 in 2023, then advanced by 4.95% to 0.65 in 2024, then fell by 0.98% to 0.64 in 2025, then rose by 2.23% to 0.66 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.66 in Q2 2026, 0.65 in Q1 2026, and 0.64 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 0.65 |
| Dec 31, 2025 | 0.64 |
| Sep 30, 2025 | 0.66 |
| Jun 30, 2025 | 0.66 |
| Mar 31, 2025 | 0.65 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.66 |
| Jun 30, 2024 | 0.63 |
| Mar 31, 2024 | 0.59 |
| Dec 31, 2023 | 0.62 |
| Sep 30, 2023 | 0.65 |
| Jun 30, 2023 | 0.67 |
| Mar 31, 2023 | 0.52 |
| Dec 31, 2022 | 0.50 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 0.45 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.55 |
| Sep 30, 2021 | 0.54 |